Cyclomics and Oxford Nanopore Technologies announce new ‘liquid biopsy’ research workflow

Using Nanopore sequencing to detect specific molecules associated with cancer circulating in the blood

Cyclomics, an UMC Utrecht spin-off originating from the research group of Associate Professor Jeroen de Ridder, in a strategic collaboration with Oxford Nanopore Technologies announced the developer access of a new ‘liquid biopsy’ research workflow using Nanopore sequencing to detect specific molecules associated with cancer circulating in the blood.

For more information please visit the Cyclomics website.